|
|
131 Varick Street, 9th floor
New York, NY 10013 USA
phone:
212-925-0741
fax:
|
| Symbol |
Private |
| Founded |
2007 |
| Employees |
5 |
|
|
 www.medicasafe.com |
|
| Research Sector |
Medical Devices & Tech |
|
|
| Summary Description |
| Integrated drug dispensing devices and usage tracking systems for increased medication adherence and compliance |
|
| Management |
| Matt Ervin, CEO |
|
|
|
|
| Keywords |
| drug delivery, medication compliance, patient monitoring, addictive drugs, risk management, disease management |
|
|
|
|
Description |
| MedicaSafe is creating solutions for medication compliance/adherence that are applicable to the real world. The company's drug dispensing devices can assure medication adherence and compliance in either commercial clinical settings or during clinical trials.
|
|
| Products / Services |
MedicaSafe provides a patent-pending drug management solution, incorporating a range of drug dispensing pillboxes and proprietary usage tracking systems facilitating patient monitoring and medication access management. MedicaSafe's products include risk management systems for 'abuse-prone' drugs and monitoring/reminder systems for 'high-stakes' medications where adherence is critical.
|
|
| Technology / Differentiation |
| Patient compliance is monitored via a centralized tracking system that can prompt the patient to correct underuse of the medication or limit drug access to prevent overuse. Additional technical information, including the details of its proprietary technology, will be made available upon request.
|
|
| Market / Customers |
Lack of adherence in a clinical setting is estimated to produce 125,000 deaths and $100 billion in healthcare costs annually. MedicaSafe's solutions are primarily applicable for clinical use with high-stakes medications, clinical use with addictive or psychiatric drugs, clinical trials and post-trial monitoring.
|
|
| Strategy |
Complete strategy, including product development milestones and strategic relationships, is available upon request.
|
|
| Funding |
| The company has been funded to date primarily via grants. |
|
| Status |
| The company announced its intent to seek series A financing in the first quarter of 2008.
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
